These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23895690)

  • 1. The renaissance of polymyxins.
    Kadar B; Kocsis B; Nagy K; Szabo D
    Curr Med Chem; 2013; 20(30):3759-73. PubMed ID: 23895690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity studies on novel polymyxin derivatives that carry only three positive charges.
    Vaara M; Vaara T
    Peptides; 2010 Dec; 31(12):2318-21. PubMed ID: 20868714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells.
    Mingeot-Leclercq MP; Tulkens PM; Denamur S; Vaara T; Vaara M
    Peptides; 2012 Jun; 35(2):248-52. PubMed ID: 22504013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Polymyxin-Like Antibiotics.
    Velkov T; Roberts KD
    Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxins: a new hope in combating Gram-negative superbugs?
    Velkov T; Roberts KD; Thompson PE; Li J
    Future Med Chem; 2016 Jun; 8(10):1017-25. PubMed ID: 27328129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
    Vaara M; Sader HS; Rhomberg PR; Jones RN; Vaara T
    J Antimicrob Chemother; 2013 Mar; 68(3):636-9. PubMed ID: 23134658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients.
    Lin YW; Aye SM; Rao G; Zhou QT; Chan HK; Li J
    Int J Antimicrob Agents; 2020 Dec; 56(6):106199. PubMed ID: 33075510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel derivatives of polymyxins.
    Vaara M
    J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
    Vaara M; Fox J; Loidl G; Siikanen O; Apajalahti J; Hansen F; Frimodt-Møller N; Nagai J; Takano M; Vaara T
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3229-36. PubMed ID: 18591267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxins and their novel derivatives.
    Vaara M
    Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.
    Velkov T; Yun B; Schneider EK; Azad MA; Dolezal O; Morris FC; Nation RL; Wang J; Chen K; Yu HH; Wang L; Thompson PE; Roberts KD; Li J
    ACS Infect Dis; 2016 May; 2(5):341-51. PubMed ID: 27627202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics.
    Mogi T; Kita K
    Cell Mol Life Sci; 2009 Dec; 66(23):3821-6. PubMed ID: 19701717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.